Screener
Krystal Biotech, Inc. KRYS Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s free cash flow margin?
- Krystal Biotech, Inc. (KRYS) reported free cash flow margin of 56.9% in Q1 2026.
- How has Krystal Biotech, Inc.'s free cash flow margin changed year-over-year?
- Krystal Biotech, Inc.'s free cash flow margin increased by 40.9% year-over-year, from 40.4% to 56.9%.
- What is the long-term trend for Krystal Biotech, Inc.'s free cash flow margin?
- Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s free cash flow margin has grown at a -50.5% compound annual growth rate (CAGR), from -198.4% to 48.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Krystal Biotech, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude